Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience

Neuroscience

Volumn 167, Issue 2, 2010, Pages 238-246

  Campos, A C ^a   Ferreira, F R ^a   Guimaraes F S ^a   Lemos, J I ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Anxiety; CB1 receptors; Endocannabinoid system; Stress; Ventral hippocampus

Indexed keywords

ENDOCANNABINOID;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CONTROLLED STUDY; FACILITATION; HIPPOCAMPUS; MALE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STRESS; VENTRAL HIPPOCAMPUS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; ENDOCANNABINOIDS; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 77950858464     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.01.062     Document Type: Article

References (62)

1. Aguiar D.C., Terzian A.L., Guimarães F.S., Moreira F.A. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology 2009, 205(2):217-225.
2. Bannerman D.M., Deacon R.M., Offen S., Friswell J., et al. Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behav Neurosci 2002, 116(5):884-901.
3. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 2004, 28(3):273-283.
4. Bannerman D.M., Yee B.K., Good M.A., Heupel M.J., et al. Double dissociation function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav Neurosci 1999, 113(6):1170-1188.
5. Beltramo M., Stella N., Calignano A., Lin S.Y., et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997, 277(5329):1094-1097.
6. Bertoglio L.J., Joca S.R., Guimaraes F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 2006, 175(1):183-188.
7. Bortolato M., Campolongo P., Mangieri R.A., Scattoni M.L., et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 2006, 31(12):2652-2659.
8. Buynitsky T., Mostofsky D.I. Restraint stress in biobehavioral research: recent developments. Neurosc Biobehav Rev 2009, 33(7):1089-1098.
9. Campos A.C., Guimaraes F.S. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 2008, 199(2):223-230.
10. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005, 29(8):1193-1205.
11. Cole B.J., Hillmann M., Seidelmann D., Klewer M., Jones G.H. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat. Psychopharmacology 1995, 121(1):118-126.
12. Conrad C.D., LeDoux J.E., Magarinos A.M., McEwen B.S. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 1999, 113(5):902-913.
13. De Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6(6):463-475.
14. Devane W.A., Hanus L., Breuer A., Pertwee R.G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258(5090):1946-1949.
15. Di Marzo V., Fontana A., Cadas H., Schinelli S., et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372(6507):686-691.
16. Diamond D.M., Fleshner M., Ingersoll N., Rose G.M. Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav Neurosci 1996, 110(4):661-672.
17. Diamond D.M., Rose G.M. Stress impairs LTP and hippocampal-dependent memory. Ann NY Acad Sci 1994, 746:411-414.
18. Echeverry M.B., Guimarães F.S., Del Bel E.A. Acute and delayed restraint stress induced changes in nitric oxide producing neurons in limbic regions. Neuroscience 2004, 125(4):981-993.
19. File S.E. Behavioural detection of anxiolytic action. Experimental approaches to anxiety and depression 1992, 25-44. Wiley, New York. J.M. Elliott, D.J. Heal, C.A. Marsden (Eds.).
20. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83(3):1017-1066.
21. Gaetani S., Cuomo V., Piomelli D. Anandamide hydrolysis: a new target for antianxiety drugs?. Trends Mol Med 2003, 9(11):474-478.
22. Galea L.A., Kavaliers M., Ossenkopp K.P. Sexually dimorphic spatial learning in meadow voles Microtus pennsylvanicus and deer mice Peromyscus maniculatus. J Exp Biol 1996, 199(Pt 1):195-200.
23. Goldman-Rakic P.S., Selemon L.D., Schwartz M.L. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 1984, 12(3):719-743.
24. Gould E., McEwen B.S., Tanapat P., Galea L.A., et al. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 1997, 17(7):2492-2498.
25. Haller J., Varga B., Ledent C., Barna I., et al. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 2004, 19(7):1906-1912.
26. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991, 11(2):563-583.
27. Hill M.N., Gorzalka B.B. Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress. Eur J Pharmacol 2004, 499(3):291-295.
28. Hill M.N., Gorzalka B.B. Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure. Psychoneuroendocrinology 2006, 31(4):526-536.
29. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30(3):508-515.
30. Hillard C.J., Campbell W.B. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. J Lipid Res 1997, 38(12):2383-2398.
31. Kathuria S., Gaetani S., Fegley D., Valino F., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003, 9(1):76-81.
32. Katona I., Freund T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 2008, 14(9):923-930.
33. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., et al. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci U S A 2002, 99(16):10825-10830.
34. Krettek J.E., Price J.L. Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat. J Comp Neurol 1977, 172(4):687-722.
35. Maisonnette S., Morato S., Brandão M.L. Role of resocialization and of 5-HT1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test. Physiol Behav 1993, 54(4):753-758.
36. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 1999, 11(12):4213-4225.
37. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346(6284):561-564.
38. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122.
39. Molchanov M.L., Guimaraes F.S. Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats. Psychopharmacology (Berl) 2002, 160(1):30-38.
40. Moreira F.A., Aguiar D.C., Guimaraes F.S. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(8):1466-1471.
41. Moreira F.A., Aguiar D.C., Guimaraes F.S. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 2007, 52(3):958-965.
42. Moreira F.A., Kaiser N., Monory K., Lutz B. Reduced anxiety-like behavior induced by genetic and pharmacological inhibition of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1receptors. Neuropharmacology 2008, 54(1):141-150.
43. Moreira F.A., Aguiar D.C., Campos A.C., Lisboa S.F., Terzian A.L., Resstel L.B., Guimarães F.S. Antiaversive effects of cannabinoids: is the periaqueductal gray involved?. Neural Plast 2009, 2009:625469.
44. Millan M.J., Brocco M. The Vogel conflict test: procedural aspects, gammaaminobutyric acid, glutamate and monoamines. Eur J Pharmacol 2003, 463(1-3):67-96.
45. Padovan C.M., Guimaraes F.S. Attenuation of behavioral consequences of immobilization stress by intra-hippocampal microinjection of zimelidine. Braz J Med Biol Res 1993, 26(10):1085-1089.
46. Padovan C.M., Guimarães F.S. Restraint-induced hypoactivity in an elevated plusmaze. Braz J Med Biol Res 2000, 33(1):79-83.
47. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 2006, 318(1):304-311.
48. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., et al. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamicpituitary-adrenal axis. Endocrinology 2004, 145(12):5431-5438.
49. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic Press, San Diego. 3rd ed.
50. Pedigo N.W., Dewey W.L., Harris L.S. Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther 1975, 193(3):845-852.
51. Petrovich G.D., Canteras N.S., Swanson L.W. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Brain Res Rev 2001, 38(1-2):247-289.
52. Rex A., Voigt J.P., Gustedt C., Beckett S., et al. Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test. Psychopharmacology 2004, 177(1-2):23-34.
53. Roohbakhsh A., Keshavarz P., Hasanein P., Rezvani M.E., et al. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours. Basic Clin Pharmacol Toxicol 2009, 105(5):333-338.
54. Rubino T., Guidali C., Vigano D., Realini N., et al. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 2008, 54(1):151-160.
55. Santos C.J., Stern C.A., Bertoglio L.J. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus. Behav Pharmacol 2008, 19(4):357-360.
56. Siegel A., Tassoni J.P. Differential efferent projections from the ventral and dorsal hippocampus of the cat. Brain Behav Evol 1971, 4(3):185-200.
57. Tasker J. Endogenous cannabinoids take the edge off neuroendocrine responses to stress. Endocrinology 2004, 145(12):5429-5430.
58. Terzian A.L., Aguiar D.C., Guimarães F.S., Moreira F.A. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. Eur Neuropsychopharmacol 2009, 19(3):188-195.
59. Tsou K., Mackie K., Sanudo-Pena M.C., Walker J.M. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 1999, 93(3):969-975.
60. Viveros M.P., Marco E.M., File S.E. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 2005, 81(2):331-342.
61. Woodmansee W.W., Silbert L.H., Maier S.F. Factors that modulate inescapable shock-induced reductions in daily activity in the rat. Pharmacol Biochem Behav 1993, 45(3):553-559.
62. Zygmunt P.M., Chuang H., Movahed P., Julius D., Högestätt E.D. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000, 396(1):39-42.